Dr. Reddy's (Weekly): Structural Rebound & Key Upside ObjectivesDescription:
Analyzing the weekly structure of Dr. Reddy's Laboratories Ltd., the price action suggests a consolidating phase with a clear roadmap for bullish continuation.
Technical Observations:
Secondary Accumulation Zone: As marked on the chart, the lower level around 1,160 is a critical supp
Dr. Reddy's Laboratories Ltd
No trades
Key facts today
Dr Reddy’s got Health Canada approval for generic semaglutide pens (2 mg, 4 mg) for once-weekly type 2 diabetes. Stock jumped ~3% prior session and is up ~10% month-to-date.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.59 USD
484.96 M USD
3.80 B USD
832.56 M
About Dr. Reddy's Laboratories Ltd.
Sector
Industry
CEO
Erez Israeli
Website
Headquarters
Hyderabad
Founded
1984
IPO date
Jan 1, 1986
Identifiers
3
ISIN US2561352038
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
Related stocks
NSE – NIFTY 750 | Dr. Reddy’s Laboratories Ltd | 17 Feb 2026Monthly structural assessment under NIFTY 750 – Structure Census.
Secular advance → regime-shift → sustained impulsive structure observed.
Current phase: Higher-range consolidation following extended multi-year advance.
Educational study only — not a recommendation.
#NIFTY750 #StructureCensus #M
Review and plan for 22nd January 2026Nifty future and banknifty future analysis and intraday plan.
stocks with quarterly results.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
Dr. Reddy's Bearish view
This setup is based on a clean break of the prior pivot low around the level (₹1,246.61), confirming bearish momentum. Defined short entry zone just below ₹1,241.09, aligning with a weekly supply zone from the higher timeframe.
The zone confluence with a weekly 50 EMA also.
🔻 Entry: Short on retr
Dr. Reddy's Bearish view
This setup is based on a clean break of the prior pivot low around the level (₹1,246.61), confirming bearish momentum. Defined short entry zone just below ₹1,241.09, aligning with a weekly supply zone from the higher timeframe.
The zone confluence with a weekly 50 EMA also.
🔻 Entry: Short on retr
A Case Study- DRREDDY Lab Probable price projectionAs it is clear from the chart it is analysed in weekly time frame
concepts used:
1. Trend and Pattern analysis
2. Pivots.
Observations:
1. price taken support along the trend channel from March 2022
2. Last week, of October 2025, candle has broken the channel successfully.
case 1. :
Dr Reddy at trend reversal ?Dr. Reddy’s – At a Make-or-Break Point on the Trendline
Dr. Reddy’s is pressing right against the lower boundary of its falling channel — a trendline that has acted as support multiple times in the recent downtrend.
Right now, the stock is hovering near ₹1,199, trying to find its footing. This lev
Dr Reddy on a falling wedge !!📊 DRREDDY – Falling Wedge Breakout Analysis
Date: August 2, 2025
CMP (Current Market Price): ₹1,220.60 ( Look for Support or breakdown on trend lines )
📝 Summary:
Dr. Reddy’s Laboratories has broken out of a falling wedge pattern on the daily chart, a classic bullish reversal setup. After weeks of
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.









